CPT Code 64640: Destruction by neurolytic agent, other peripheral nerve

Found our content helpful?

Key takeaways

CPT Code 64640 covers neurolytic destruction of peripheral nerve branches that no more specific code in the 64600-64681 range describes.

The code requires destruction of the nerve. Temporary, device-based cryoneurolysis is reported with Category III codes 0440T-0442T instead.

Medical necessity documentation must establish that conservative treatment failed before 64640 is billed.

Modifier 50 covers bilateral same-session procedures. Modifier 59, or XS for Medicare, separates distinct nerve sites billed on one date.

Practice management software like Pabau embeds documentation checklists at the point of care, so 64640 claims go out complete.

CPT Code 64640 is the billable procedure code for destruction by neurolytic agent of a peripheral nerve or branch.

The descriptor comes from the American Medical Association (AMA) CPT code set. Pain management practices report it for chemical, thermal, and cryogenic procedures that permanently interrupt a peripheral pain-signal pathway.

Two conditions decide whether 64640 is the right choice. The nerve has to be destroyed rather than blocked, and it has to be a branch with no dedicated code. This guide covers the clinical indications, documentation requirements, modifiers, ICD-10 crosswalk, 2026 Medicare context, and the denial triggers that follow.

What is CPT Code 64640?

CPT Code 64640 is the AMA-designated code for neurolytic destruction of a peripheral nerve or branch with no more specific code. The codes it defers to run from 64600 through 64681. Destruction may be achieved chemically, thermally, by radiofrequency, or by freezing.

The official descriptor reads Destruction by neurolytic agent, other peripheral nerve or branch. The word “other” carries the rule. If a named nerve has its own code, that code wins.

The intercostal nerve is 64620. Paravertebral facet joint nerves are 64633 through 64636. CPT 64640 applies only when the treated branch falls outside those named categories.

A destruction code, and payers read it that way

64640 sits in the CPT surgery section for the nervous system, under the heading “Destruction by Neurolytic Agent.” Payers read that heading literally. They expect the operative note to describe destruction, and to show that reversible options were tried and failed.

Clinical indications and medical necessity for CPT Code 64640

Medical necessity is the most commonly cited denial reason on 64640 claims. Payers want documented evidence that the targeted nerve transmits pathological pain. They also want proof that conservative treatment failed, and that destruction suits this patient better than a repeatable block.

Accepted clinical indications across most Local Coverage Determination (LCD) policies include:

• Chronic peripheral neuropathic pain unresponsive to medication, physical therapy, or diagnostic nerve blocks
• Cancer-related pain where the affected peripheral nerve is the primary pain generator
• Chronic pain syndromes involving peripheral branches such as the occipital, ilioinguinal, or genitofemoral nerve
• Post-surgical neuropathic pain with identifiable peripheral nerve involvement
• Painful peripheral nerve entrapment refractory to conservative management

Cryoneurolysis and the 64640 code-selection trap

Cryoneurolysis is where 64640 is most often the wrong code. CMS Medicare Coverage Database article A59753 states that 64640 is not valid for temporary, non-destructive cryoneurolysis devices such as Iovera.

64640 requires destruction of the nerve. Where a device produces only a temporary conduction block, A59753 points to the Category III codes 0440T through 0442T. Coverage rules still vary by Medicare Administrative Contractor (MAC), so confirm the applicable LCD as well.

Procedure overview: Neurolytic destruction methods

Three modalities fall within the scope of CPT 64640. Matching the operative note to the right one keeps the documentation consistent with the code on the claim.

Imaging guidance is billed separately with the appropriate guidance code. Use 77002 for fluoroscopy and 76942 for ultrasound. The guidance code and 64640 report distinct clinical services, so they are not bundled together.

CPT 64640 documentation requirements

Thorough records are the most effective defense against a 64640 denial. Every chart note supporting the claim should carry these elements:

• Nerve specificity: Identify the exact peripheral nerve or branch treated, never a generic “peripheral nerve”
• Failed conservative care: Document duration, modalities tried, and the patient’s response to each
• Diagnostic block results: A prior block, often 64450 or a named-nerve code, confirming the target nerve is the pain generator
• Neurolytic agent or modality: State whether chemical, thermal, or cryogenic destruction was used
• Imaging guidance: Confirm fluoroscopic or ultrasound guidance if a guidance code is billed alongside 64640
• Informed consent: Signed consent documenting the permanent or semi-permanent nature of the destruction
• Laterality: Specify left, right, or bilateral if Modifier 50 or LT/RT is applied

Nerve specificity is where most operative notes fall short. A note reading “neurolytic block performed” without naming the nerve is a near-certain denial.

Billing guidelines for CPT Code 64640

Three billing rules cause most of the avoidable 64640 errors, even among experienced pain management coders.

Use the most specific code available

64640 is the “other” code. If a more specific neurolysis code exists for the nerve treated, that code must be used instead. Billing 64640 for a procedure better described by 64620 or 64633 is an unbundling violation and an audit risk.

Multiple nerve procedures on the same date

CPT 64640 may be reported more than once on the same date when distinct nerve sites are treated. Each additional unit must be documented as a separate procedure on a separate branch. Append Modifier 59, or XS for Medicare, to each additional unit. Without it, the claim usually denies as a duplicate.

Global surgery period

CPT 64640 carries a 10-day global surgery period under the Medicare Physician Fee Schedule. Follow-up services related to the procedure are included in the payment during that window. Billing a separate E/M service inside the global period requires Modifier 24 or Modifier 25.

Modifier 24 covers an unrelated E/M visit. Modifier 25 covers a significant, separately identifiable E/M on the same day as the procedure.

Flag the global period end date on the claim record so the front desk does not bill a follow-up visit twice. Building that check into the scheduling system beats catching it manually at billing review.

Modifiers for CPT 64640

Modifier assignment is the second most common source of 64640 claim errors. The table below covers the modifiers pain management billers apply most often.

Modifier 50 is billed as a single line with the modifier appended, and many payers reimburse it at 150% of the single-side rate. Some commercial payers instead want two lines, one LT and one RT, at 100% each. Check your contracts before defaulting to the Modifier 50 format.

ICD-10 codes commonly paired with CPT Code 64640

The ICD-10 diagnosis code has to support medical necessity for the destruction. Payers cross-reference it against their LCD to confirm coverage. The pairings below are widely accepted, though necessity is still established per patient and per payer policy.

ICD-10 code M54.5 (Low back pain) was retired on October 1, 2021, and replaced by M54.50, M54.51, and M54.59. Submitting M54.5 now produces an automatic technical denial. Check each pairing against the ICD-10-CM code library, or the CDC/NCHS ICD-10-CM lookup tool, before the claim cycle.

Medicare coverage and reimbursement for CPT Code 64640

Medicare covers CPT Code 64640 when medical necessity criteria are met under the applicable MAC Local Coverage Determination. Coverage is not uniform across MACs, because peripheral nerve destruction policies differ by jurisdiction. Confirm the applicable LCD before treating Medicare beneficiaries.

2026 fee schedule and facility versus non-facility rates

Reimbursement for 64640 depends on where the procedure is performed. Facility rates, which apply in ambulatory surgery centers and hospital outpatient departments, sit below non-facility office rates. Verify the 2026 amounts in the CMS Physician Fee Schedule lookup tool, since rates change annually and vary by locality.

As a benchmark, non-facility reimbursement for peripheral nerve destruction codes in this family has typically run from $200 to $450 per nerve site. Treat that as a range, not a rate. Confirm current figures for your own MAC jurisdiction before any revenue projection.

Routing claims through a clearinghouse connected to your practice management platform keeps eligibility checks ahead of the procedure date. Pabau’s Claim.MD integration connects to thousands of US payers and returns electronic remittance advice into the same record. Practices can then reconcile 64640 payments against the expected fee schedule amount.

Prior authorization requirements

Prior authorization requirements for 64640 vary by MAC and by commercial payer. Some MACs require prior auth for peripheral nerve destruction, and others do not. Commercial payers often want documentation of failed conservative treatment with the request. Run benefit checks before scheduling, so you know which rule applies to each patient’s plan.

Common denial reasons and how to avoid them

Most 64640 denials fall into a small number of categories. Recognizing the pattern is the first step toward a denial management process that moves the rate.

• Lack of medical necessity: Notes fail to document failed conservative care, or do not identify the specific nerve as the pain generator. Fix: require diagnostic block documentation before the procedure is scheduled.
• Missing or incorrect modifier: Bilateral procedures submitted without Modifier 50 or LT/RT, or multiple sites without Modifier 59 or XS. Fix: put a modifier decision tree in the billing workflow.
• Wrong code used: 64640 billed when a more specific neurolysis code applies, such as 64633 for a paravertebral facet nerve. Fix: train coders on the 64600-64681 hierarchy.
• Missing prior authorization: The procedure was performed without the authorization the plan required. Fix: verify auth requirements at scheduling, not at billing.
• Retired or invalid ICD-10 code: M54.5 submitted instead of the current M54.5x codes. Fix: audit the crosswalk against the current year’s CMS code list every October.
• Cryoneurolysis billed as destruction: A temporary, non-destructive device reported under 64640. Fix: report 0440T-0442T for those devices per CMS article A59753, and reserve 64640 for documented nerve destruction.

Review the previous quarter’s denied 64640 claims as a batch. The pattern tells you whether the cause is documentation, modifiers, or prior auth, and each of those needs a different operational fix.

Related CPT codes: When to use each

CPT Code 64640 is the residual “other peripheral nerve” code. Before billing it, confirm that no named-nerve or site-specific code describes the procedure better. The chart below reduces that check to five documented scenarios.

The 64450 versus 64640 line is the one that carries audit risk. Both describe peripheral nerve interventions, but 64450 reports a reversible anesthetic injection while 64640 reports destruction. Billing one when the other was performed is a coding error with audit consequences.

The table below compares 64640 with its closest related codes, sourced from the AAPC Codify CPT reference.

How claims management software supports CPT 64640 billing

The most effective way to reduce 64640 denials is to move the compliance check upstream, to the point of care. A biller cannot create medical necessity after the visit is over. The chart note is the claim.

Practice management software like Pabau combines documentation templates, modifier logic, and eligibility verification in one workflow. For a pain management practice billing 64640 regularly, Pabau’s claims management software adds four checks:

• Documentation templates: Procedure note fields for nerve name, agent type, imaging guidance, and prior block date, so the note cannot be finalized incomplete
• Eligibility verification at scheduling: Payer checks that confirm coverage and prior authorization before the procedure date
• Modifier prompts: Suggestions drawn from how the procedure was configured, so staff are not applying Modifier 50 or 59 from memory
• Denial trend reporting: Analytics that surface 64640 denial patterns by denial code and root cause across the whole team

Practices that build the documentation standard into the clinical workflow spend less time on rework. The denial gets prevented in the treatment room, while the detail is still in front of the clinician.

Reduce 64640 denials before they happen

Pabau embeds documentation checklists, modifier reminders, and automated eligibility checks into your pain management workflow, so claims go out complete the first time.

Book a demo

Conclusion

64640 is a short descriptor sitting on top of four separate judgment calls. Name the nerve, prove conservative care failed, pick the modifier that matches the session, and confirm the note describes destruction.

Get those four right at the point of care and the claim needs no rework. Get one wrong and the appeal costs more staff time than the procedure earned. That trade-off is why the fix belongs in the note template, not the billing queue.

Book a demo to see how Pabau puts the 64640 documentation checklist, modifier prompts, and eligibility check in front of your team.

Continue your research

Want to understand how clearinghouse claim routing works? Medical claims clearinghouse guide explains how claims move from practice to payer and where 64640 submissions can stall.

Need a structured approach to billing errors? Claim.MD clearinghouse overview covers how Pabau routes claims to thousands of US payers with real-time status tracking.

Looking to reduce your denial backlog? Credentialing with insurance companies covers the upstream credentialing steps that prevent eligibility-based denials on pain management claims.

Frequently asked questions